Shenglan Gao

998 citations
44 papers · 645 indexed · h-index 16
Topics
RNA modifications and cancer (5 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers)MicroRNA in disease regulation (4 papers)

In The Last Decade

Shenglan Gao

42 papers receiving 644 citations

Peers

Shenglan Gao
Comparison fields: 5 of 85
  • Molecular Biology 396
  • Cancer Research 181
  • Pulmonary and Respiratory Medicine 145
  • Oncology 96
  • Biochemistry 60
Replace Alberto Delaidelli with:
Alberto Delaidelli Canada
Valérie Domergue France
Roger Nadrowitz Germany
Mathieu Vernier Canada
Danijela Đokić United States
Guosheng Yang China
Jie Pan China
Mitra Kooshki United States
Molly R. Seaward United States
Shenglan Gao relative to Alberto Delaidelli Canada Alberto Delaidelli's profile →
Citations per field
00.5×5.3×
Alberto Delaidelli · 1×
Citations per year

Countries citing papers authored by Shenglan Gao

Since Specialization
Citations

This map shows the geographic impact of Shenglan Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Gao more than expected).

Fields of papers citing papers by Shenglan Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Gao. The network helps show where Shenglan Gao may publish in the future.

Co-authorship network of co-authors of Shenglan Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Gao. A scholar is included among the top collaborators of Shenglan Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Gao. Shenglan Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 24
3 2
4 1
5 5
6 2
7 3
8 41
9 10
10 113
11 9
12 3
13 8
14 43
15 18
16 2
17 51
18 22
19 19
20 16

About Shenglan Gao

Shenglan Gao is a scholar working on Cancer Research, Biochemistry and Molecular Biology, having authored 44 papers that have together received 645 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (181 citations), Biochemistry (60 citations) and Molecular Biology (396 citations). Shenglan Gao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wei‐Xing Zong, Hua Xiao, Chengliang Zhang, Aimin Li, Yongbo Wang, Gang Liu, Yahong Wang, Jianliang Shen, Zeqing Song and Ziying Lin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026